Skip to main content

Market Overview

Healthways Surges Over 10% Following UBS Upgrade, Insiders' Share Acquisitions

Share:
Healthways Surges Over 10% Following UBS Upgrade, Insiders' Share Acquisitions

Shares of Healthways, Inc. (NASDAQ: HWAY) were trading up over 11 percent midday Tuesday following an upgrade from UBS Global Research and four insider transactions over the past two trading days.

After the market close on November 1, Healthways reported Q3 earnings, falling short of analyst expectations (adjusted EPS of $0.30 vs. $0.52 estimate) and slightly beating sales ($125 million vs. $124.7 million estimate.)

After reporting, the company’s shares fell more than 22 percent over the next two trading days before experiencing insider buys from the company CEO and two directors.

  • November 4: Healthways CEO Tramuto Donato bought 33,175 shares at $20.25/share, increasing his stake by around $671,793.
  • November 7: Donato bought 5,060 shares at $19.95/share, increasing his stake by an additional $100,947.
  • November 7: Director Lee Shapiro bought 1,266 shares at $19.53/share, increasing his stake by $24,724.
  • November 7: Director Robert Greczyn bought 5,000 shares at $19.55/share, increasing his total stake by $97,750.

On Tuesday, UBS Global Research Analyst A. J. Rice upgraded Healthways from Sell to Buy, while increasing his 12-month price target from $22.50 to $24. Following the upgrade, shares were trading up over 11 percent in early trading.

Latest Ratings for HWAY

DateFirmActionFromTo
Jan 2017JefferiesUpgradesHoldBuy
Nov 2016UBSUpgradesSellBuy
Aug 2016UBSDowngradesNeutralSell

View More Analyst Ratings for HWAY
View the Latest Analyst Ratings

 

Related Articles (HWAY)

View Comments and Join the Discussion!

Posted-In: Analyst Color Long Ideas News Upgrades Health Care Price Target Insider Trades Analyst Ratings Best of Benzinga

Latest Ratings

StockFirmActionPT
NIUDaiwa CapitalInitiates Coverage On41.5
QMCONorthland Capital MarketsInitiates Coverage On12.0
IBKRJefferiesInitiates Coverage On89.0
MRETFTD SecuritiesDowngrades18.5
SWKSGoldman SachsDowngrades135.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com